Nanjing Shihao Pharmaceutical Technology

Nanjing Shihao Pharmaceutical Technology is a specialized pharmaceutical research and development company based in Nanjing, China. The firm operates primarily as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) with a focus on high-end generic drugs and innovative small molecule therapeutics. Their expertise spans chemical process development, API synthesis, and advanced formulation research, particularly for complex molecules. Shihao Pharma has established a significant portfolio in therapeutic areas such as cardiovascular disease, oncology, and metabolic disorders. By providing technical transfer and high-quality intermediates, the company supports both domestic and international pharmaceutical partners in accelerating drug commercialization.